{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:37:55Z","timestamp":1792813075845,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["2021H082"],"award-info":[{"award-number":["2021H082"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-024-03447-w","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T11:01:57Z","timestamp":1728644517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Integrin \u03b25, a noninvasive diagnostic biomarker, is associated with unfavorable prognosis and immunotherapy efficacy in gastric cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Yangyang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingcheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"key":"3447_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"3447_CR2","doi-asserted-by":"crossref","unstructured":"Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int J Mol Sci. 2020;21(11):4012.","DOI":"10.3390\/ijms21114012"},{"key":"3447_CR3","doi-asserted-by":"crossref","unstructured":"Thanh Huong P, Gurshaney S, Thanh Binh N, Gia Pham A, Hoang Nguyen H, Thanh Nguyen X, et al. Emerging Role of Circulating Tumor Cells in Gastric Cancer. Cancers (Basel). 2020;12(3):695.","DOI":"10.3390\/cancers12030695"},{"key":"3447_CR4","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.3748\/wjg.v24.i21.2236","volume":"24","author":"TT Li","year":"2018","unstructured":"Li TT, Liu H, Yu J, Shi GY, Zhao LY, Li GX. Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells. World J Gastroenterol. 2018;24:2236\u201346.","journal-title":"World J Gastroenterol"},{"key":"3447_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1001\/jamasurg.2022.0182","volume":"157","author":"GZ Li","year":"2022","unstructured":"Li GZ, Doherty GM, Wang J. Surgical Management of Gastric Cancer: a review. JAMA Surg. 2022;157:446\u201354.","journal-title":"JAMA Surg"},{"key":"3447_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12551-013-0124-0","volume":"6","author":"LR Anderson","year":"2014","unstructured":"Anderson LR, Owens TW, Naylor MJ. Structural and mechanical functions of integrins. Biophys Rev. 2014;6:203\u201313.","journal-title":"Biophys Rev"},{"key":"3447_CR7","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41556-018-0220-2","volume":"20","author":"JG Lock","year":"2018","unstructured":"Lock JG, Jones MC, Askari JA, Gong X, Oddone A, Olofsson H, et al. Reticular adhesions are a distinct class of cell-matrix adhesions that mediate attachment during mitosis. Nat Cell Biol. 2018;20:1290\u2013302.","journal-title":"Nat Cell Biol"},{"key":"3447_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18:533\u201348.","journal-title":"Nat Rev Cancer"},{"key":"3447_CR9","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.4161\/cc.9.8.11517","volume":"9","author":"A Bianchi","year":"2010","unstructured":"Bianchi A, Gervasi ME, Bakin A. Role of \u03b25-integrin in epithelial-mesenchymal transition in response to TGF-\u03b2. Cell Cycle. 2010;9:1647\u201359.","journal-title":"Cell Cycle"},{"key":"3447_CR10","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/s41388-022-02225-w","volume":"41","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Dho SE, Othman K, Simpson CD, Lapierre J, Bondoc A, et al. Numb exon 9 inclusion regulates Integrin\u03b25 surface expression and promotes breast cancer metastasis. Oncogene. 2022;41:2079\u201394.","journal-title":"Oncogene"},{"key":"3447_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3892\/etm.2023.12231","volume":"26","author":"L Ma","year":"2023","unstructured":"Ma L, Song K, Zang J. Integrin \u03b25 is an independent prognostic marker for intrahepatic cholangiocarcinoma in a Chinese population. Exp Ther Med. 2023;26:532.","journal-title":"Exp Ther Med"},{"key":"3447_CR12","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.7150\/thno.69605","volume":"12","author":"P Peng","year":"2022","unstructured":"Peng P, Zhu H, Liu D, Chen Z, Zhang X, Guo Z, et al. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin \u03b1v\u03b25-Src-Stat3 signaling. Theranostics. 2022;12:4221\u201336.","journal-title":"Theranostics"},{"key":"3447_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41389-020-0190-7","volume":"9","author":"T Hirano","year":"2020","unstructured":"Hirano T, Shinsato Y, Tanabe K, Higa N, Kamil M, Kawahara K, et al. FARP1 boosts CDC42 activity from integrin \u03b1v\u03b25 signaling and correlates with poor prognosis of advanced gastric cancer. Oncogenesis. 2020;9:13.","journal-title":"Oncogenesis"},{"key":"3447_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.21037\/atm.2020.03.184","volume":"8","author":"Q Li","year":"2020","unstructured":"Li Q, Peng K, Chen E, Jiang H, Wang Y, Yu S, et al. IntegrinB5 upregulated by HER2 in gastric cancer: a promising biomarker for liver metastasis. Ann Transl Med. 2020;8:451.","journal-title":"Ann Transl Med"},{"key":"3447_CR15","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10120-014-0435-2","volume":"18","author":"C B\u00f6ger","year":"2015","unstructured":"B\u00f6ger C, Warneke VS, Behrens HM, Kalthoff H, Goodman SL, Becker T, et al. Integrins \u03b1v\u03b23 and \u03b1v\u03b25 as prognostic, diagnostic, and therapeutic targets in gastric cancer. Gastric Cancer. 2015;18:784\u201395.","journal-title":"Gastric Cancer"},{"key":"3447_CR16","doi-asserted-by":"publisher","first-page":"770997","DOI":"10.3389\/fonc.2021.770997","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Sun Y, Xu J, Yang H, Liu X, Tian Y, et al. Integrin-\u03b26 serves as a potential prognostic serum biomarker for gastric Cancer. Front Oncol. 2021;11:770997.","journal-title":"Front Oncol"},{"key":"3447_CR17","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"3447_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16:284\u20137.","journal-title":"Omics"},{"key":"3447_CR19","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3447_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137.","journal-title":"Nat Methods"},{"key":"3447_CR21","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35:4200\u20132.","journal-title":"Bioinformatics"},{"key":"3447_CR22","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.bbagen.2012.04.016","volume":"1820","author":"WY Hung","year":"2012","unstructured":"Hung WY, Huang KH, Wu CW, Chi CW, Kao HL, Li AF, et al. Mitochondrial dysfunction promotes cell migration via reactive oxygen species-enhanced \u03b25-integrin expression in human gastric cancer SC-M1 cells. Biochim Biophys Acta. 2012;1820:1102\u201310.","journal-title":"Biochim Biophys Acta"},{"key":"3447_CR23","doi-asserted-by":"publisher","first-page":"76816","DOI":"10.18632\/oncotarget.20161","volume":"8","author":"L Shang","year":"2017","unstructured":"Shang L, Ye X, Zhu G, Su H, Su Z, Chen B, et al. Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma. Oncotarget. 2017;8:76816\u201331.","journal-title":"Oncotarget"},{"key":"3447_CR24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3389\/fonc.2019.00904","volume":"9","author":"LY Zhang","year":"2019","unstructured":"Zhang LY, Guo Q, Guan GF, Cheng W, Cheng P, Wu AH. Integrin Beta 5 is a prognostic biomarker and potential therapeutic target in Glioblastoma. Front Oncol. 2019;9:904.","journal-title":"Front Oncol"},{"key":"3447_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm2593","volume":"10","author":"B Geiger","year":"2009","unstructured":"Geiger B, Spatz JP, Bershadsky AD. Environmental sensing through focal adhesions. Nat Rev Mol Cell Biol. 2009;10:21\u201333.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3447_CR26","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1038\/onc.2012.320","volume":"32","author":"A Bianchi-Smiraglia","year":"2013","unstructured":"Bianchi-Smiraglia A, Paesante S, Bakin AV. Integrin \u03b25 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene. 2013;32:3049\u201358.","journal-title":"Oncogene"},{"key":"3447_CR27","first-page":"1108","volume":"6","author":"S Wang","year":"2016","unstructured":"Wang S, Xie J, Li J, Liu F, Wu X, Wang Z. Cisplatin suppresses the growth and proliferation of breast and cervical cancer cell lines by inhibiting integrin \u03b25-mediated glycolysis. Am J Cancer Res. 2016;6:1108\u201317.","journal-title":"Am J Cancer Res"},{"key":"3447_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","volume":"698","author":"S Noorolyai","year":"2019","unstructured":"Noorolyai S, Shajari N, Baghbani E, Sadreddini S, Baradaran B. The relation between PI3K\/AKT signalling pathway and cancer. Gene. 2019;698:120\u20138.","journal-title":"Gene"},{"key":"3447_CR29","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/jcb.25496","volume":"117","author":"V Syed","year":"2016","unstructured":"Syed V. TGF-\u03b2 signaling in Cancer. J Cell Biochem. 2016;117:1279\u201387.","journal-title":"J Cell Biochem"},{"key":"3447_CR30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12885-016-2621-6","volume":"16","author":"C Cho","year":"2016","unstructured":"Cho C, Horzempa C, Jones D, McKeown-Longo PJ. The fibronectin III-1 domain activates a PI3-Kinase\/Akt signaling pathway leading to \u03b1v\u03b25 integrin activation and TRAIL resistance in human lung cancer cells. BMC Cancer. 2016;16:574.","journal-title":"BMC Cancer"},{"key":"3447_CR31","doi-asserted-by":"crossref","unstructured":"Neophytou CM, Panagi M, Stylianopoulos T, Papageorgis P. The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities. Cancers (Basel). 2021;13(9):2053.","DOI":"10.3390\/cancers13092053"},{"key":"3447_CR32","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1038\/onc.2013.257","volume":"33","author":"SM W\u00f6rmann","year":"2014","unstructured":"W\u00f6rmann SM, Diakopoulos KN, Lesina M, Alg\u00fcl H. The immune network in pancreatic cancer development and progression. Oncogene. 2014;33:2956\u201367.","journal-title":"Oncogene"},{"key":"3447_CR33","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443\u201354.","journal-title":"N Engl J Med"},{"key":"3447_CR34","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366:2455\u201365.","journal-title":"N Engl J Med"},{"key":"3447_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41571-018-0138-4","volume":"16","author":"JW Carlisle","year":"2019","unstructured":"Carlisle JW, Ramalingam SS. A banner year for immunotherapy and targeted therapy. Nat Rev Clin Oncol. 2019;16:79\u201380.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"3447_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/85339","volume":"2","author":"AI Chapoval","year":"2001","unstructured":"Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol. 2001;2(3):269\u201374.","journal-title":"Nat Immunol"},{"key":"3447_CR37","doi-asserted-by":"publisher","first-page":"701006","DOI":"10.3389\/fimmu.2021.701006","volume":"12","author":"WT Zhou","year":"2021","unstructured":"Zhou WT, Jin WL. B7-H3\/CD276: an Emerging Cancer Immunotherapy. Front Immunol. 2021;12:701006.","journal-title":"Front Immunol"},{"issue":"1","key":"3447_CR38","doi-asserted-by":"publisher","first-page":"113414","DOI":"10.1016\/j.yexcr.2022.113414","volume":"422","author":"Q Gao","year":"2023","unstructured":"Gao Q, Cui L, Huang C, Chen Z, Wang X, Wen S, et al. Gastric cancer-derived mesenchymal stem cells promote gastric cancer cell lines migration by modulating CD276 expression. Exp Cell Res. 2023;422(1):113414.","journal-title":"Exp Cell Res"},{"key":"3447_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10637-012-9842-6","volume":"31","author":"C Manegold","year":"2013","unstructured":"Manegold C, Vansteenkiste J, Cardenal F, Schuette W, Woll PJ, Ulsperger E, et al. Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer. Invest New Drugs. 2013;31:175\u201382.","journal-title":"Invest New Drugs"},{"key":"3447_CR40","doi-asserted-by":"publisher","first-page":"15018","DOI":"10.18632\/oncotarget.7588","volume":"7","author":"M Weller","year":"2016","unstructured":"Weller M, Nabors LB, Gorlia T, Leske H, Rushing E, Bady P, et al. Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome. Oncotarget. 2016;7:15018\u201332.","journal-title":"Oncotarget"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03447-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03447-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03447-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T23:18:23Z","timestamp":1728688703000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03447-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3447"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03447-w","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out after the protocol was approved by the Human Research Ethics Committee of the Harbin Medical University Cancer Hospital. I confirm that all methods were performed in accordance with the relevant guidelines. All procedures were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments, and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"362"}}